Overview
Catalog No.
DHC00801
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Human
Isotype
[(scFv-heavy-kappa)-IGHE-CH4]2
Clonality
Monoclonal
Target
Cold-insoluble globulin, CIG, FN, Fibronectin, FN1
Concentration
0.66 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Purified by Nickel column.
Accession
P02751
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
PBS PH 6.0,10% sucrose, 0.02% Tween 80.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
L19-131 I, L19-SIP, CAS: 1253180-81-2
Clone ID
Radretumab
Data Image
References
Radretumab radioimmunotherapy in patients with brain metastasis: a 124I-L19SIP dosimetric PET study, PMID: 24777501
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies, PMID: 22577235
Nanotrastuzumab in combination with radioimmunotherapy: Can it be a viable treatment option for patients with HER2-positive breast cancer with brain metastasis?, PMID: 26880645
ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach., PMID:35681572
Nanotrastuzumab in combination with radioimmunotherapy: Can it be a viable treatment option for patients with HER2-positive breast cancer with brain metastasis?, PMID:26880645
Radretumab radioimmunotherapy in patients with brain metastasis: a 124I-L19SIP dosimetric PET study., PMID:24777501
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies., PMID:22577235
Datasheet
For research use only. Not for human or drug use.
